Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amerise Biosciences Ltd held a board meeting on 2 February 2026 and approved the unaudited financial results for the quarter and nine months ended 31 December 2025, though actual numbers were not disclosed in this intimation. The board appointed Mr. Albert Hines (DIN: 10742692), aged 25 with around 3 years of experience in accounts and finance, as the new Whole-time Director and Chief Financial Officer. In a simultaneous move, the outgoing Whole-time Director and CFO, Mr. Dinesh Rathod, resigned citing pre-occupation with other work. The company is formerly known as Amradeep Industries Limited and carries scrip code 531681 on BSE.
The CFO change on the same day may raise governance questions given the new appointee's young age and limited experience, though the resignation cites personal reasons. Investors should look at the actual Q3 FY26 results when filed separately to assess financial health, as no numbers were shared in this update.